Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jun;4(2):203-205.
doi: 10.1007/s41669-020-00216-9.

Learnings for Health Economics From the Early Stages of the COVID-19 Pandemic

Affiliations
Free PMC article
Editorial

Learnings for Health Economics From the Early Stages of the COVID-19 Pandemic

Anthony J Hatswell. Pharmacoecon Open. .
Free PMC article

Conflict of interest statement

Anthony J. Hatswell has no conflicts of interest that are directly relevant to the content of this article.

Similar articles

See all similar articles

References

    1. Haeussler K, Marcellusi A, Mennini FS, et al. Cost-effectiveness analysis of universal human papillomavirus vaccination using a dynamic bayesian methodology: The BEST II Study. Value Health. 2015;18(8):956–968. doi: 10.1016/j.jval.2015.08.010. - DOI - PubMed
    1. Bermejo I, Tappenden P, Youn J-H. Replicating health economic models: firm foundations or a house of cards? Pharmacoeconomics. 2017;35(11):1113–1121. doi: 10.1007/s40273-017-0553-x. - DOI - PubMed
    1. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341–364. doi: 10.1016/S0167-6296(98)00039-3. - DOI - PubMed
    1. Wintle BC, Fraser H, Wills BC, Nicholson AE, Fidler F. Verbal probabilities: very likely to be somewhat more confusing than numbers. PLoS ONE. 2019;14(4):e0213522. doi: 10.1371/journal.pone.0213522. - DOI - PMC - PubMed
    1. Scientific Advisory Group for Emergencies (SAGE). Potential impact of behavioural and social interventions on a Covid-19 epidemic in the UK. 2020. https://www.gov.uk/government/groups/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-response. Accessed 30 Mar 2020.

Publication types

LinkOut - more resources

Feedback